Fosamprenavir how supplied: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
== | ==How Supplied/Storage and Handling== | ||
LEXIVA Tablets, 700 mg, are pink, film-coated, capsule-shaped, biconvex tablets, with “GX LL7” debossed on one face. | * LEXIVA Tablets, 700 mg, are pink, film-coated, capsule-shaped, biconvex tablets, with “GX LL7” debossed on one face. | ||
Bottle of 60 with child-resistant closure (NDC 49702-207-18). | : Bottle of 60 with child-resistant closure (NDC 49702-207-18). | ||
Store at controlled room temperature of 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Keep container tightly closed. | : Store at controlled room temperature of 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Keep container tightly closed. | ||
LEXIVA Oral Suspension, a white to off-white grape-bubblegum-peppermint–flavored suspension, contains 50 mg of fosamprenavir as fosamprenavir calcium equivalent to approximately 43 mg of amprenavir in each 1 mL. | * LEXIVA Oral Suspension, a white to off-white grape-bubblegum-peppermint–flavored suspension, contains 50 mg of fosamprenavir as fosamprenavir calcium equivalent to approximately 43 mg of amprenavir in each 1 mL. | ||
Bottle of 225 mL with child-resistant closure (NDC 49702-208-53). | : Bottle of 225 mL with child-resistant closure (NDC 49702-208-53). | ||
This product does not require reconstitution. | : This product does not require reconstitution. | ||
Store in refrigerator or at room temperature (5° to 30°C; 41° to 86°F). Shake vigorously before using. | : Store in refrigerator or at room temperature (5° to 30°C; 41° to 86°F). Shake vigorously before using. | ||
: Do not freeze.<ref>{{Cite web | last = | first = | title = LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED LEXIVA (FOSAMPRENAVIR CALCIUM) SUSPENSION [VIIV HEALTHCARE COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24feb9be-32a6-45fd-a896-f3e202edd8a9 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 19:25, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
How Supplied/Storage and Handling
- LEXIVA Tablets, 700 mg, are pink, film-coated, capsule-shaped, biconvex tablets, with “GX LL7” debossed on one face.
- Bottle of 60 with child-resistant closure (NDC 49702-207-18).
- Store at controlled room temperature of 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Keep container tightly closed.
- LEXIVA Oral Suspension, a white to off-white grape-bubblegum-peppermint–flavored suspension, contains 50 mg of fosamprenavir as fosamprenavir calcium equivalent to approximately 43 mg of amprenavir in each 1 mL.
- Bottle of 225 mL with child-resistant closure (NDC 49702-208-53).
- This product does not require reconstitution.
- Store in refrigerator or at room temperature (5° to 30°C; 41° to 86°F). Shake vigorously before using.
- Do not freeze.[1]
References
Adapted from the FDA Package Insert.